Updates

Categories
  1. TheSocialMedwork commitment during the COVID-19 outbreak

    Here are some frequently asked questions and answers that touch on important COVID-19 related updates.

    Read more »
  2. Promising new data analysis for Alzheimer’s disease treatment

    New analysis of Biogen’s aducanumab shows reduction in clinical decline in Alzheimer’s disease.

    Xray of human brain

    Read more »
  3. MN-166 (ibudilast) to enter phase III clinical trials for progressive MS

    MN-166 (ibudilast) will be part of the Phase III clinical trial on progressive multiple sclerosis subjects with secondary progressive MS without relapses. 

    pipette samples

    Read more »
  4. Phase 2 study: Ibudilast's effects in progressive MS

    Phase 2 clinical trial shows that ibudilast is linked to a 48% slowing in the progression of brain atrophy compared to placebo for patients with progressive MS.

    red mri brain scan

    Read more »
  5. New cancer medicine targets tumour biomarkers anywhere in the body

    The new site-agnostic cancer medicine, Vitrakvi (larotrectinib), gets accelerated approval from the U.S. Food and Drug Administration (FDA).

    US flag thumbs up gesture

    Read more »
  6. Lung cancer medicine receives positive opinion in the EU

    CHMP's assessment supports EMA's approval of non-small cell lung cancer (NSCLC) medicine, Vizimpro (dacomitinib).

    EU approval OK hand gesture

    Read more »
  7. Cancer medicine, Lartruvo (olaratumab), does not prolong life

    After failing to show a clear benefit over chemotherapy on its own, both the FDA and EMA do not recommend Lartruvo (olaratumab) for use in combination with chemotherapy for new STS patients.

    old bench

    Read more »
  8. Truxima (rituximab) gains FDA approval as the first biosimilar for Non-Hodgkin's Lymphoma

    A new biosimilar, Truxima (rituximab), shows comparable results to the reference medicine, Rituxan (rituximab), and takes FDA one step further toward expanding patient access to medicines.

    approved stamp with stars

    Read more »
  9. Vyndaqel (tafamidis) prolongs life of FAP patients

    Positive news for patients with early-stage FAP; results from a Portuguese study show that a liver transplant or Vyndaqel may extend survivability.

    grandfather pointing into sea

    Read more »
  10. A new gene therapy on the horizon for SMA

    Zolgensma (onasemnogene abeparvovec-xxxx) to receive priority review by FDA as a one-time treatment of type 1 spinal muscular atrophy (SMA).

    baby outside reaching toward viewer

    Read more »
  11. Bavencio (avelumab) misses ovarian cancer trial endpoints

    A late-stage study testing Bavencio (avelumab) has failed to meet its primary endpoints in patients with certain forms of ovarian cancer.

    woman backlit sun field

    Read more »
  12. Ocrevus (ocrelizumab) helps preserve hand and arm function in PPMS

    In an exploratory study Ocrevus (ocrelizumab) slowed down loss of function in the upper extremities for patients with primary progressive multiple sclerosis (PPMS).

    woman raised hands near water

    Read more »
  13. Where data and humanity meet: an algorithm to improve medicine pricing models

    Industry NewsHow two professors imagine a better world for stakeholders in the medical industry. 

    Read more »
  14. Mystery around a high-risk leukaemia solved

    "These results offer a leap in understanding about this disease that provides a genetically based framework for designing clinical trials to develop more effective treatments of MPAL," 

    High-Risk Leukaemia

    Read more »
  15. New method promises fewer side effects from cancer drugs

    "In short, it will help produce drugs where we can be far more confident about where modifications are being made, so that side effects can be minimized in the future"

    Fewer Side Effects

    Read more »
  16. Breast Cancer: New indicators found to help in prognosis for the most aggressive form

    Researchers report a successful classification of triple breast cancer patients, which for the first time, would allow doctors to discern between those who can be cured and those who might suffer a relapse. 

    Triple Negative Breast Cancer

    Read more »
  17. Stem cells as a new drug delivery tool for childhood brain cancer?

    "This is a great avenue of exploration, particularly for the 30 percent of children who struggle or don't make it with standard therapy."

    Stem Cell drug delivery in Brain Cancer

    Read more »
  18. Deep brain stimulation leads to increased understanding of Parkinson's disease

    These findings increase our understanding of how the brain is affected by Parkinson's disease...

    Parkinsons' Deep Brain Stimulation

    Read more »
  19. Study finds that new Multiple Sclerosis drug slows down brain shrinkage

    "These findings provide a glimmer of hope for people with a form of multiple sclerosis that causes long-term disability but does not have many treatment options,"

    MS Progressive study

    Read more »
  20. New study uses focussed ultrasound to deliver anti-cancer drugs across the blood brain barrier

    "By laying the groundwork for more rational design and deeper understanding of focused-ultrasound-based treatment, our work could help improve treatment of any brain tumor -- primary or metastatic -- and could also revolutionize approaches to immunotherapy of tumors by improving localized delivery of tumor-killing immune cells."

    Blood Brain research

    Read more »
  21. Majority of former and current cancer patients are happy with their life

    "These findings of incredible mental flourishing even in the context of cancer is a wonderful testament to the resiliency of patients and an encouraging message for patients, their families and their health care providers" stated Fuller-Thomson.

    Cancer patients happy

    Read more »
  22. Keeping cancer out of breath blocks drug resistance

    "The best part is that our combined drug candidate was so much more effective than one of the most powerful cancer drugs on the market," said Jonathan Sessler

    cancer out of breath

    Read more »
  23. Acute leukemia: Drug trials show 50% cure rate

    "We were thrilled to see such a dramatic change even after only a single dose of the new drug. Nearly all of the lab mice's leukemia signs disappeared overnight," said Professor Ben-Neriah.

    Drug Trials 50% Cure rate

    Read more »
  24. Deleting two molecules boosts immune response

    "Our findings could provide an opportunity to improve future engineering of CAR T cells against tumors...."

    Cancer, 2 molecules

    Read more »
  25. Genetic model could be the ideal new tool for testing Parkinson's disease therapies.

    "We believe we've found an approach that is most relevant to humans, in that our models of gene dysfunction mimic the etiology of Parkinson's disease rather than its pathology....

    News on Parkinsons

    Read more »
  26. New research findings about Huntington's disease

    This opens up new treatment strategies for diseases that involve impairment of the body's ability to break down...

    News from research

    Read more »
  27. New subtype of multiple sclerosis discovered

    The breakthrough provides a better understanding of the individualized nature of the disease says the research team. 

    MS new type

    Read more »
  28. Lower prices negotiated on 16 medicines

    Lower prices negotiated and provided as part of our ongoing mission to make medicines more accessible. 
    new prices 

    Read more »
  29. A new answer for treating migraines?

    7 need-to-knows about migraine as well as some updates on the latest treatment developments

    Blog post

    Read more »
  30. Image of the Year shows exceptional responses to cancer treatment

    Industry NewsThe dramatic before-and-after images show eight men's incredible response to cutting-edge treatment. 

    Read more »
Page
CA